The transaction received unanimous support across BayMark’s capital structure, materially strengthened its balance sheet and provided growth capital to support long term stability and sustainable growth. 

Based in Lewisville, Texas, BayMark is North America’s leading provider of comprehensive substance use disorder treatment and recovery services, serving more than 70,000 patients each day.